Role of patient characteristics in adherence to first-line treatment guidelines in breast, lung and prostate cancer: insights from the Nordic healthcare system

dc.contributor.authorSandström Niclas
dc.contributor.authorLeppälä Emilia
dc.contributor.authorJekunen Antti
dc.contributor.authorJohansson Mikael
dc.contributor.authorAndersén Heidi
dc.contributor.organizationfi=kliininen syöpätautioppi|en=Clinical Oncology|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.74978886054
dc.converis.publication-id387714584
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/387714584
dc.date.accessioned2025-08-27T21:27:39Z
dc.date.available2025-08-27T21:27:39Z
dc.description.abstract<p><strong>Objectives</strong> This study investigates the influence of socioeconomic status, health literacy, and numeracy on treatment decisions and the occurrence of adverse events in patients with breast, lung, and prostate cancer within a Nordic healthcare setting.</p><p><strong>Design</strong> A follow-up to a cross-sectional, mixed-methods, single-centre study.</p><p><strong>Setting</strong> A Nordic, tertiary cancer clinic.</p><p><strong>Participants</strong> A total of 244 participants with breast, lung and prostate cancer were initially identified, of which 138 first-line treatment participants were eligible for this study. First-line treatment participants (n=138) surpassed the expected cases (n=108).</p><p><strong>Interventions</strong> Not applicable as this was an observational study.</p><p><strong>Primary and secondary outcome measures</strong> The study’s primary endpoint was the rate of guideline adherence. The secondary endpoint involved assessing treatment toxicity in the form of adverse events.</p><p><strong>Results</strong> Guideline-adherent treatment was observed in 114 (82.6%) cases. First-line treatment selection appeared uninfluenced by participants’ education, occupation, income or self-reported health literacy. A minority (3.6%) experienced difficulties following treatment instructions, primarily with oral cancer medications.</p><p><strong>Conclusions</strong> The findings indicated lesser cancer health disparities regarding guideline adherence and treatment toxicity within the Nordic healthcare framework. A causal connection may not be established; however, the findings contribute to discourse on equitable cancer health provision.</p>
dc.identifier.eissn2044-6055
dc.identifier.jour-issn2044-6055
dc.identifier.olddbid200430
dc.identifier.oldhandle10024/183457
dc.identifier.urihttps://www.utupub.fi/handle/11111/46575
dc.identifier.urlhttps://bmjopen.bmj.com/content/14/4/e084689
dc.identifier.urnURN:NBN:fi-fe2025082785013
dc.language.isoen
dc.okm.affiliatedauthorSandström, Niclas
dc.okm.affiliatedauthorJekunen, Antti
dc.okm.affiliatedauthorAndersen, Heidi
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBMJ Group
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumbere084689
dc.relation.doi10.1136/bmjopen-2024-084689
dc.relation.ispartofjournalBMJ Open
dc.relation.issue4
dc.relation.volume14
dc.source.identifierhttps://www.utupub.fi/handle/10024/183457
dc.titleRole of patient characteristics in adherence to first-line treatment guidelines in breast, lung and prostate cancer: insights from the Nordic healthcare system
dc.year.issued2024

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
e084689.full.pdf
Size:
384.7 KB
Format:
Adobe Portable Document Format